Short Interest Sector Focus: Utilities Sector

As of the close of business on Friday, 9/30, we captured the Top 10 Highest Short Interest % stocks within the Utilities Sector. The average short interest for stocks within the Utilities sector stands at 2.05%. Therefore, the below stocks are showing a more pessimistic outlook than their peers within the respective sector.  

As of the close of business on Friday, 9/30, we captured the Top 10 Highest Short Interest % stocks within the Utilities Sector.

The average short interest for stocks within the Utilities sector stands at 2.05%. Therefore, the below stocks are showing a more pessimistic outlook than their peers within the respective sector.

 

  • ORMAT TECHNOLOGIES    (NYSE:ORA)    13.16%
  • NRG ENERGY INC        (NYSE:NRG)    8.39%
  • PORTLAND GEN ELEC    (NYSE:POR)    7.13%
  • ATMOS ENERGY CORP    (NYSE:ATO)    6.79%
  • SPIRE INC        (NYSE:SR)    5.43%
  • BLACK HILLS CORP    (NYSE:BKH)    5.03%
  • PNM RES INC        (NYSE:PNM)    4.98%
  • ONE GAS INC        (NYSE:OGS)    4.74%
  • SOUTH JERSEY INDS    (NYSE:SJI)    4.48%
  • ENTERGY CORP        (NYSE:ETR)    4.46%

Short Interest is the percentage of a stocks’ outstanding shares being sold short, which is utilized as a gauge for stock price sentiment. When short interest increases, this is generally considered a negative “bear” market indicator, whereas when short interest decreases, this is generally considered a positive “bull” market indicator. 

Disclaimer:
The Short Interest Indicator is produced by Tidal Markets, in partnership with Benzinga Insights. The data represented is exclusive to short interest data amalgamated daily by Tidal Markets LLC and its underlying proprietary sources. The information contained herein should not be compared to, contrasted, or evaluated against other short interest data providers. ANY INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE OR IMPLY INVESTMENT ADVICE

Total
0
Shares
Related Posts
Read More

Sensei Biotherapeutics Signs Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI) to Expand Development Plan for SNS-101, a Conditionally Active VISTA-blocking Antibody

Under the terms of the CRADA, Sensei will collaborate with the NCI Center for Immuno-Oncology Co-Directors, Jeffrey Schlom, Ph.D., and James Gulley, M.D., Ph.D., and conduct preclinical studies to assess the mechanism of

SNSE